Stopping Alzheimer’s may begin with dissolving tiny tau protein clusters before damage takes hold.

Tau protein aggregation is a shared feature in over 20 neurodegenerative diseases (collectively referred to as "tauopathies"). New research led by Boston Children's Hospital challenges the current ...

A new drug developed by Australian researchers has shown promising results in reducing sepsis in a Phase II clinical trial involving 180 patients. The carbohydrate-based treatment works by calming a ...

Scientists have long observed that cancer patients have a lower risk of Alzheimer’s disease. New research reveals a possible ...

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. appointed a new chair and 10 new public members to the Advisory Council on Alzheimer's Research, Care, and Services, the department said ...

A new study in mice suggests that memory problems in Alzheimer’s disease may stem from a breakdown in how the brain replays recent experiences during periods of rest. The research was carried out by s ...

We're tracking major new developments about CTE, or Chronic Traumatic Encephalopathy, the deadly brain disease caused by ...

Alzheimer’s may destroy memory by flipping a single molecular switch that tells neurons to prune their own connections. Researchers found that both amyloid beta and inflammation converge on the same ...

New study offers hope of reversing Alzheimer’s by restoring brain energy. CLEVELAND, Jan 21: Researchers in Cleveland have successfully reversed advanced Alzheimer’s disease in mice, achieving full ...

A brand-new paper has just been published that claims to challenge the century-old dogma that Alzheimer’s disease is ...

Lithium refiner Mangrove Water Technologies Inc. secured $85 million from the Canada Growth Fund, BMW AG’s i Ventures and Bill Gates-backed Breakthrough Energy LLC. The “structured financing package” ...